
AxoGen AXGN
$ 33.22
1.87%
Quarterly report 2025-Q2
added 08-05-2025
AxoGen EV - Enterprise Value 2011-2026 | AXGN
Annual EV - Enterprise Value AxoGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 932 M | 462 M | 428 M | 441 M | 906 M | 489 M | 593 M | 915 M | 316 M | 133 M | 80.4 M | 60 M | 48 M | 10.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 932 M | 10.3 M | 415 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
994 M | $ 7.01 | 2.04 % | $ 503 M | ||
|
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.76 | -1.7 % | $ 130 M | ||
|
Alphatec Holdings
ATEC
|
1.41 B | $ 13.29 | 1.41 % | $ 1.9 B | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
Bio-Rad Laboratories
BIO
|
10.1 B | $ 255.19 | -12.51 % | $ 7.2 B | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
3.81 B | $ 36.35 | -3.09 % | $ 5.42 K | ||
|
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
3.26 B | $ 41.59 | -0.28 % | $ 1.28 B | ||
|
Boston Scientific Corporation
BSX
|
155 B | $ 74.77 | 0.88 % | $ 110 B | ||
|
Abbott Laboratories
ABT
|
228 B | $ 112.22 | 0.66 % | $ 195 B | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
EDAP TMS S.A.
EDAP
|
252 M | $ 4.8 | 0.63 % | $ 179 M | ||
|
Delcath Systems
DCTH
|
350 M | $ 9.25 | 1.43 % | $ 264 M | ||
|
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
459 M | $ 13.44 | 3.07 % | $ 363 M | ||
|
Electromed
ELMD
|
170 M | $ 24.2 | 3.82 % | $ 205 M | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | ||
|
Inogen
INGN
|
203 M | $ 5.71 | -1.38 % | $ 135 M | ||
|
InMode Ltd.
INMD
|
3.99 B | $ 14.36 | 0.38 % | $ 1.14 B | ||
|
IRadimed Corporation
IRMD
|
629 M | $ 99.81 | -0.03 % | $ 1.26 B | ||
|
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | ||
|
Integer Holdings Corporation
ITGR
|
5.99 B | $ 85.46 | 0.23 % | $ 2.87 B | ||
|
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | ||
|
Penumbra
PEN
|
10.5 B | $ 339.82 | 0.32 % | $ 13.1 B | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
91.5 M | $ 18.55 | 0.05 % | $ 122 M | ||
|
Pulmonx Corporation
LUNG
|
347 M | $ 1.47 | 3.17 % | $ 57.5 M | ||
|
Globus Medical
GMED
|
11.7 B | $ 87.89 | 0.76 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.13 B | $ 11.29 | 4.46 % | $ 869 M | ||
|
Myomo
MYO
|
4.1 M | $ 0.82 | 0.41 % | $ 5.78 M | ||
|
Establishment Labs Holdings
ESTA
|
1.41 B | $ 75.22 | 2.28 % | $ 2.12 B |